[Gallbladder Cancer: Is It Time to Modify the Explicit Health Guarantees (GES) Program?]

IF 0.3
Revista medica de Chile Pub Date : 2024-10-01 Epub Date: 2025-02-03 DOI:10.4067/s0034-98872024001001028
Camila P Samaniego, Xabier de Aretxabala, Felipe Castillo, Álvaro Paredes, M Trinidad González
{"title":"[Gallbladder Cancer: Is It Time to Modify the Explicit Health Guarantees (GES) Program?]","authors":"Camila P Samaniego, Xabier de Aretxabala, Felipe Castillo, Álvaro Paredes, M Trinidad González","doi":"10.4067/s0034-98872024001001028","DOIUrl":null,"url":null,"abstract":"<p><p>Chile currently has one of the highest mortality rates from gallbladder cancer in the world. In 2006, the Chilean Ministry of Health included cholelithiasis (patients aged 35-49) and treatment with cholecystectomy within the Explicit Health Guarantees (GES) program.</p><p><strong>Aim: </strong>To evaluate the results of the GES Preventive Cholecystectomy Program for Gallbladder Cancer as to consider the need to propose changes to the model.</p><p><strong>Methods: </strong>retrospective analysis of official data from the Chile Ministry of Health and National Statistics Institute.</p><p><strong>Results: </strong>Since the program's inception in 2006, 284.139 notifications have been issued to patients aged between 35 and 49 with gallstones. Notifications can be correlated with the number of cholecystectomies performed under the program. Gallbladder cancer standardized mortality has shown a decrease over the last two decades, even before the program was implemented. High and low incidences are observed throughout the country. Regarding notifications, there are areas with a high incidence that are not always correlated with the areas with high notifications.</p><p><strong>Conclusion: </strong>The decrease in the standardized mortality of GBC in Chile requires modifying the present GES Preventive Cholecystectomy program for Gallbladder Cancer. Resources should be oriented to patients living in high-incidence areas with known risk factors.</p>","PeriodicalId":101370,"journal":{"name":"Revista medica de Chile","volume":"152 10","pages":"1028-1037"},"PeriodicalIF":0.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica de Chile","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4067/s0034-98872024001001028","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Chile currently has one of the highest mortality rates from gallbladder cancer in the world. In 2006, the Chilean Ministry of Health included cholelithiasis (patients aged 35-49) and treatment with cholecystectomy within the Explicit Health Guarantees (GES) program.

Aim: To evaluate the results of the GES Preventive Cholecystectomy Program for Gallbladder Cancer as to consider the need to propose changes to the model.

Methods: retrospective analysis of official data from the Chile Ministry of Health and National Statistics Institute.

Results: Since the program's inception in 2006, 284.139 notifications have been issued to patients aged between 35 and 49 with gallstones. Notifications can be correlated with the number of cholecystectomies performed under the program. Gallbladder cancer standardized mortality has shown a decrease over the last two decades, even before the program was implemented. High and low incidences are observed throughout the country. Regarding notifications, there are areas with a high incidence that are not always correlated with the areas with high notifications.

Conclusion: The decrease in the standardized mortality of GBC in Chile requires modifying the present GES Preventive Cholecystectomy program for Gallbladder Cancer. Resources should be oriented to patients living in high-incidence areas with known risk factors.

胆囊癌:是时候修改明确健康保障(GES)计划了吗?]
智利目前是世界上胆囊癌死亡率最高的国家之一。2006年,智利卫生部将胆石症(35-49岁患者)和胆囊切除术治疗纳入明确健康保障方案。目的:评价GES预防胆囊切除术治疗胆囊癌的效果,以考虑是否需要对该模型进行修改。方法:回顾性分析智利卫生部和国家统计局的官方数据。结果:自2006年该项目启动以来,已向35至49岁胆结石患者发出284.139份通知。通知可以与在该计划下进行的胆囊切除术的数量相关联。在过去的二十年中,甚至在该项目实施之前,胆囊癌的标准化死亡率就已经有所下降。全国各地的发病率有高有低。关于通报,有些高发地区并不总是与通报率高的地区相关。结论:智利GBC标准化死亡率的降低需要修改目前的GES胆囊癌预防性胆囊切除术方案。资源应面向生活在已知危险因素的高发病率地区的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信